1.625GBp-2.30%Mkt Cap: 2.71M GBpP/E: —Last update: 2026-05-13
BSF Enterprise Plc, together with its subsidiaries, develops and commercializes cell-based tissue engineering solutions in the United Kingdom and Hong Kong. The company acquires businesses in the biotechnology, marketing…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B0.06
P/S51.32
EV/EBITDA-0.02
EV/Revenue0.47
EPS (TTM)-0.01
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-23.55%
FCF Margin-1208.59%
Operating CF-1.01M GBp
CapEx (TTM)10.35K GBp
Net Debt/EBITDA0.13
Net Debt-149.02K GBp
Technical
SMA 501.457 (+11.6%)
SMA 2002.101 (-22.6%)
Beta3.59
S&P 52W Chg24.23%
Avg Vol (30d)9.69M
Avg Vol (10d)10.53M
Technical Indicators
RSI (14)48.0
MACD0.0381
MACD Signal0.0801
MACD Hist.-0.0419
BB Upper1.991 GBp
BB Middle1.733 GBp
BB Lower1.476 GBp
BB Width29.71%
ATR (14)0.4972 GBp
Vol Ratio (20d)7.01x
52W Range
0.500032% of range4.000
52W High4.000 GBp
52W Low0.5000 GBp
Profitability
Gross Margin-34.37%
EBITDA Margin0.00%
Profit Margin-2107.36%
Oper. Margin-1099.44%
ROE-40.97%
ROA-37.03%
Revenue Growth815.50%
Earnings Growth—
Balance Sheet
Debt/Equity0.00
Current Ratio1.70
Quick Ratio1.38
Book Value/Sh0.2540 GBp
Cash/Share0.0140 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:12
Split DateFeb 27, 2026
Ownership
Shares Out.166.87M
Float7.35M
Insiders22.75%
Institutions0.03%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap2.71M GBp
Enterprise Value24.82K GBp
Revenue (TTM)52.84K GBp
Gross Profit-18.16K GBp
Net Income (TTM)-1.11M GBp
Revenue/Share0.0050 GBp
Fiscal Year EndSep 2025
MR QuarterSep 2025
Employees14
Last Price1.625 GBp
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINUS00182C1036